Download Citation
Article Source:
Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate
Currier JR,
Ngauy V,
de Souza MS,
Ratto-Kim S,
Cox JH,
et al.
(2010)
Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate.
PLOS ONE 5(11): e13983.
https://doi.org/10.1371/journal.pone.0013983